2023-03-20 08:12:23 ET
- Esperion ( NASDAQ: ESPR ) entered into a definitive agreement with healthcare-focused institutional investors for the issuance and sale of 33.1M shares and short-term warrants in a registered direct offering.
- Each share is sold with one short-term warrant to purchase one share at a combined purchase price of $1.675.
- The short-term warrants will be immediately exercisable on issuance, will expire three and a half years post issuance date and have an exercise price of $1.55/share.
- Offer closing is expected on or about Mar.22, 2023.
- Gross proceeds are seen at $56.7M; net proceeds to be used for general corporate purposes.
For further details see:
Esperion in red on pricing $56.7M in stock and short-term warrants offering